Piershale Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$57.6K Buy
348
+1
+0.3% +$161 0.04% 36
2023
Q1
$53.7K Buy
347
+1
+0.3% +$161 0.04% 33
2022
Q4
$61K Buy
+346
New +$59.7K 0.05% 24
2016
Q4
Sell
-566
Closed -$67K 76
2016
Q3
$67K Buy
566
+1
+0.2% +$121 0.05% 30
2016
Q2
$69K Sell
565
-105
-16% -$11.9K 0.05% 27
2016
Q1
$72K Buy
670
+302
+82% +$31.3K 0.04% 24
2015
Q4
$38K Buy
368
+2
+0.5% +$201 0.02% 47
2015
Q3
$34K Buy
366
+2
+0.5% +$193 0.03% 39
2015
Q2
$35K Buy
364
+2
+0.6% +$200 0.03% 35
2015
Q1
$36K Buy
362
+1
+0.3% +$102 0.03% 38
2014
Q4
$38K Buy
361
+2
+0.6% +$211 0.02% 49
2014
Q3
$38K Buy
359
+4
+1% +$415 0.03% 43
2014
Q2
$37K Buy
355
+101
+40% +$10.2K 0.03% 54
2014
Q1
$25K Buy
254
+7
+3% +$649 0.03% 54
2013
Q4
$23K Buy
247
+1
+0.4% +$92 0.03% 43
2013
Q3
$21K Buy
246
+120
+95% +$10.8K 0.02% 54
2013
Q2
$11K Buy
+126
New +$10.7K 0.02% 51

Other funds holding JNJ

Piershale Financial Group's JNJ Position: Q2 2023 in Review

Piershale Financial Group increased its Johnson & Johnson (JNJ) stake by 0.29% in Q2 2023, buying an estimated $161 and bringing the position to 348 shares worth $57.6K. The position accounts for 0.04% of the portfolio, ranked #36.

Piershale Financial Group first reported a position in JNJ in Q2 2013 and has held it in 17 quarters since. The position peaked at $72K in Q1 2016. 3,752 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • Piershale Financial Group held 348 shares of Johnson & Johnson worth $57.6K as of Q2 2023.
  • Piershale Financial Group bought 1 Johnson & Johnson share in Q2 2023, an estimated $161.
  • Johnson & Johnson made up 0.04% of Piershale Financial Group's portfolio in Q2 2023, its #36 holding.
  • Piershale Financial Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 17 quarters since.
  • Piershale Financial Group's Johnson & Johnson position peaked at $72K in Q1 2016.
  • 3,752 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Piershale Financial Group's 13F filing for Q2 2023, filed 6 Jul 2023.